Orgenesis

+$0.09 (+1.89%) As of 6:06 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Orgenesis and other ETFs, options, and stocks.

About ORGS

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. It operates through the Contract Development and Manufacturing Organization (CDMO) and Point-Of-Care Cell Therapy (POC) segments.

CEO
Vered Caplan
Employees
111
Headquarters
Germantown, Maryland
Founded
2008

ORGS Key Statistics

Market Cap
117.74M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
42.99K
High Today
$4.85
Low Today
$4.76
Open Price
$4.80
Volume
10.68K
52 Week High
$8.30
52 Week Low
$4.14

ORGS Earnings

-$1.26
-$0.06
$1.13
$2.33
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure